Skip to Content

Bionoid Pharma Inc Ordinary Shares BINP

Morningstar Rating
$0.45 +0.25 (124.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

BINP is trading at a 39% discount.
Price
$0.20
Fair Value
$3.44
Uncertainty
Extreme
1-Star Price
$3.86
5-Star Price
$4.65
Economic Moat
Wjvnz
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BINP is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.20
Day Range
$0.450.45
52-Week Range
$0.041.04
Bid/Ask
$0.05 / $0.25
Market Cap
$6,679.68
Volume/Avg
100 / 4,375

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Bionoid Pharma Inc is a cannabis company that cultivates, extracts, tests, and distributes organic hemp, cannabinoid, and related products. Its products aid in decreasing pain, improving recovery time, enhancing performance, and enhance physical well-being.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Total Number of Employees
13

Valuation

Metric
BINP
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
BINP
Quick Ratio
0.14
Current Ratio
0.17
Interest Coverage
−527.14
Quick Ratio
No chart available

Profitability

Metric
BINP
Return on Assets (Normalized)
−1,430.83%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AZptxfjscRmvh$77.2 Bil
MKKGY
Merck KGaA ADRGjvfrhchbGsmvk$75.4 Bil
HLN
Haleon PLC ADRBpbwmbscjZlr$38.1 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRCbkhhczDscms$16.0 Bil
VTRS
Viatris IncRkwtfbfbjLlrtf$14.0 Bil
RDY
Dr Reddy's Laboratories Ltd ADRQwlbkrvLpnv$12.1 Bil
CTLT
Catalent IncBzkfnpsFlwrtvw$10.2 Bil
PRGO
Perrigo Co PLCVhlnlnpplYzfw$4.3 Bil
CURLF
Curaleaf Holdings IncPrvydhzjzQcz$4.0 Bil
PBH
Prestige Consumer Healthcare IncYcxclgwgKsdpmz$3.6 Bil

Sponsor Center